BuzzRx: Prescription Discounts
71
Quality Score
Strong
BuzzRx: Prescription Discounts
Medium confidence
✍️ bumetric analysis
“
BuzzRx: Prescription Discounts is an iOS app from Buzz Group Holdings LLC in the Education category, currently rated 4.8★ across 3,266 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 71: Strong (healthy traction). For a Education app, that means healthy traction. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$740
per month
→
12-mo forecast
$647 – $2332
per month
→
24-mo forecast
$599 – $5394
per month
INDIE tierFREE
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🤖Also on Android
$187/mo · 41 ratings · 4.2★
View →
ONE-TIME · BUILD💰 Estimated build cost
$95K
↳ What it cost to build · not monthly revenue
Likely range $70K – $130K
$25K · MVP floor$100K · indie scale$500K+ · studio build
📈Pays back in ~12 months at current MRR
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱MVP baseline (design + 1-store ship) | +$28K |
| 📱5 unique screens × $4.5K | +$22K |
| ⚙Education complexity ×1.20 | +$10K |
| ⚙5.6y maintenance × ~1-person team | +$33K |
Total estimate$95K
ONE-TIME · EXIT VALUE💵 Estimated acquisition value
$175K
↳ What it would sell for · not monthly revenue
Marketplace range $125K – $225K · 22× MRR multiple
💸~1.8× build cost (break-even+)
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
How the multiple was built
| 📺Ad-supported base | 15× MRR |
| 📅5.6y proven track record | +20% |
| ⭐★ rating ≥ 4.7 (premium) | +15% |
| 🏷Education category multiple | +6% |
Final multiple22× MRR
👥 Estimated audience size
195K
Lifetime downloads (US-equivalent)
Monthly active
27K
Daily active
8.1K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲Education engagement | ~85 installs / rating |
| 📅5.6y of rating accumulation | -28% |
| 🔁Education D30 retention | 18% |
| 📍DAU / MAU stickiness | 0.30 |
DAU / MAU30% sticky
🛠 Estimated tech stack
🍎
Native iOS (SwiftUI)
High confidence · 80%
Also possible
Native iOS (Swift / UIKit)
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
Signals we read
| 📦App bundle size | 25 MB |
| 🏷Category context | Education |
| 📦Compact iOS bundle | → Native SwiftUI (post-2020 era) |
💀 Maintenance status
Slowing
30%
Last shipped 2026-01-05 · 140 days ago
0 · Active50 · At risk100 · Abandoned
Heuristic risk score from time-since-last-update + ratings velocity proxy + Editor's Choice / curated featuring signals. Calibrated against 2024-2025 app-store ranking decay reports. Not a guarantee — a quiet app with a healthy codebase looks the same as an abandoned one until something breaks. Full math on /methodology.
Risk signals
| 📅4 months since last update | Slowing cadence |
VerdictSlowing
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$740/mo · ML-estimated from 234 triggers
Growth rate
+6.0% MoM · INDIE tier baseline (compound monthly)
6 months
$630 – $1.5K
12 months
$647 – $2.3K
24 months
$599 – $5.4K
Compound growth at +6.0% MoM (tier baseline for INDIE). Range widens with horizon — typical noise band ±40% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Early-stage solo · 41/100INDIE TIERFREE (NO MONETIZATION)expected for tierGrowth Velocity
5.0
Founder Strength
4.9
Product Quality
7.2
Revenue Strength
2.9
Monetization Maturity
0.5
Defensibility
3.4
Market Position
0.3
Operational Safety
8.5
- 💰 Revenue: Marginal — $296 - $1850/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.85★ across 3,266 reviews — solid.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — rating drift -0.39 ★ (recent 50 vs lifetime).
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $13K-$23K. Portfolio play ($8K/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 6 of 6 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Excellent rating (4.8★)METRIC | +$2,200 | |
| Low install base (3,266 ratings)METRIC | +$1,500 | |
| highly recommendREVIEW | +$1,400 | |
| Established app (5y old)METRIC | +$800 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Single-language (English only)METRIC | −$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
App Specs
🔐 Own this app? Claim & verify MRR →💾 25 MB🔞 12+📱 iOS 13.0+🔖 v1.63🔄 updated 4mo ago🌐 EN📂 Education💰 Paid🚀 Launched 2020 (5y old)
📝 About this app
BuzzRx: Your Rx Savings Prescription Care Partner! Save on prescriptions with BuzzRx, the ultimate savings app for local Rx discounts. Need to save on prescription meds, at Walgreens, Walmart, CVS, Safeway, and Rite Aid? Or perhaps you need a prescription refill? BuzzRx has you covered! Navigate our Rx coupons to get unbeatable pharmacy discounts right in your neighborhood!
Why BuzzRx?
Save on prescriptions: Find prescription discounts at Walgreens, Walmart, CVS, Rite Aid, and over 60,000 pharmacies nationwide.… View full description on the official store →
Why BuzzRx?
Save on prescriptions: Find prescription discounts at Walgreens, Walmart, CVS, Rite Aid, and over 60,000 pharmacies nationwide.… View full description on the official store →
🆕 What's New · v1.63
- Bug fixes and performance enhancements.
📅
What Worked™ · Development Pipeline
6 EVENTS TRACKEDDetected changes in this app over its tracked lifetime — each event links cause (what changed) to effect (what moved). Sorted newest first.See full history →Version history →
2026-05
🔄
Monetization changed: freemium → free
2026-03
⭐
Rating ↑ 4.58 → 4.90 (improved 0.32★)
2026-03
📈
Crossed 100 ratings — social-proof flywheel kicking in
2024-04
📈
Crossed 50 ratings — social-proof flywheel kicking in
2020-11
📈
Crossed 10 ratings — social-proof flywheel kicking in
2020-10
🚀
First tracked snapshot — initial data captured
🗣
Voice of Customer
Based on 64 reviews across 1 markets● 91% positive · ● 6% neutral · ● 3% negative · Rating drift: -0.39★ (declining — recent 50: 4.46★ vs lifetime: 4.85★)
VADER compound sentiment per quarter (−1 = fully negative, +1 = fully positive). Each point ≥ 5 reviews.
Top praise themes
saves money ×5 covered insurance ×5 saved over ×5 save money ×5 saved money ×4 highly recommend ×4 life saver ×4 money prescriptions ×4
Top complaint themes
prices ×4 don ×4 donate ×4 wish ×4 money ×4 pharmacy ×3 company ×3
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- BuzzRx: Prescription Discounts
- Developer
- Buzz Group Holdings LLC
- Bundle ID
- io.pdcgs.buzzrxconsumer
- App Store URL
- Open in App Store
- Category
- Education
- Content rating
- 12+
- Languages
- EN
Company
- Website
- Not found
- Tagline
- Today
- Description
- Find apps and games for iPhone, iPad, Mac, and more on the App Store.
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Available
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $8.1K/mo
- Top-grossing rank
- Outside top 100 in US Education
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth3,266 ratings+46557% lifetimeShow 3-year history estimate ▾
Tracked (41 weeks) Pre-tracking estimate (36 weeks) · model-based, ±5% noise · anchored to release date and current value
🌍Geographic ReachNot ranked
This app is currently outside the top 100 grossing in all 9 countries we monitor (US, UK, DE, FR, JP, CA, AU, BR, IN). Niche or new apps often launch this way — popularity rankings appear once daily revenue clears the regional threshold.
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 Description
95
BU Score · Transcendent
❓ Frequently Asked Questions
Who is the author of The ?
The author is , a prominent figure in the study of occult philosophy and esoteric traditions.
What is the main theme of the book?
The main theme is the esoteric interpretation of the Book of Revelation, focusing on the mystical and symbolic meanings hidden within the text.
Why is this book important for modern esoteric seekers?
This book is important because it bridges ancient wisdom with contemporary spiritual practices, providing valuable insights into the esoteric traditions that have influenced Western spirituality.
Full revenue analysis
Read the article-style breakdown for BuzzRx: Prescription Discounts: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
About this analysis
Why medium confidence: 3,266 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
10 answers · auto-generated from this app's public dataHow much does BuzzRx make per month?▴
Based on our ML-calibrated revenue forecast, BuzzRx earns approximately $8.1K/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
Is BuzzRx profitable?▴
With estimated build cost $95K and monthly revenue $8.1K, BuzzRx looks profitable — pays back its estimated build cost in roughly 12 months at the current run-rate. Profitability also depends on paid-acquisition spend and refund rate which the public model doesn't see.
How many users does BuzzRx have?▴
Estimated audience: ~195K lifetime downloads, ~27K monthly active users, and ~8K daily active users. Derived from ratings count × category installs-per-rating × age decay. US-storefront-equivalent — global audience can be 5-10× larger for internationally-distributed apps.
What apps are like BuzzRx?▴
Browse the full Education category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
What is BuzzRx built with?▴
Our heuristic places BuzzRx on the Native iOS (SwiftUI) stack (High confidence, 80%). Signals: app bundle size, category context, store-description markers, release-date era. We don't disassemble binaries. Alternative possibilities: Native iOS (Swift / UIKit).
Is BuzzRx still actively maintained?▴
Maintenance status: Slowing (30% abandonment risk). Last shipped version was 4 months ago. The risk score combines time-since-last-update with Editor's Choice / curated featuring + user-base maturity adjustments.
How much would BuzzRx sell for?▴
Estimated acquisition value: $175K (marketplace range $125K – $225K). Calculated as 22× monthly revenue using the standard multiple for the detected monetization model + adjustments for age, rating quality and category demand. Calibrated against 2024-2026 Flippa / Acquire.com / MicroAcquire closed-deal medians.
When was BuzzRx last updated?▴
BuzzRx last shipped a new version on 2026-01-05 — 4 months ago. This is the date Apple / Google last accepted a new build, not a content-only push.
Who makes BuzzRx?▴
BuzzRx is published by Buzz Group Holdings LLC on the Apple App Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is BuzzRx's BU Score?▴
BuzzRx has a BU Score of 71/100 (Strong). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.